XNCR - Xencor, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
12.43 1.67 (13.44%)	---	---	---	0.03 (0.24%)	1.52 (12.08%)	0.0 (0.0%)	-0.08 (-0.64%)

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.41
Diluted EPS:: -0.41
Basic P/E:: -34.3902
Diluted P/E:: -34.3902
RSI(14) 1m:: 44.19
VWAP:: 14.08
RVol:: 0.8981

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	14.17 +0.16 (+1.14%)	Oct 15 13:26
10m	Price decrease 10m	13.27 -0.49 (-3.56%)	Oct 15 10:17
10m	Price increase 10m	13.7 +0.4 (+3.05%)	Oct 15 10:07
Day	Price increase day	13.7 +1.27 (+10.22%)	Oct 15 10:07
10m	Price increase 10m	13.38 +0.45 (+3.47%)	Oct 15 09:58